Other ways to significantly reduce neutrophil infiltration after administration of cisplatin include the use of TNF-α inhibitors, TLR-4 antagonists, or anti-intercellular adhesion molecule-1 antibodies (53), thereby partially improving cisplatin-induced AKI. This evidence concerns the gene TNF and acute kidney injury.